Literature DB >> 23689806

Frequency and risk factors of renal insufficiency in inflammatory bowel disease inpatients.

Brian Lewis1, Saurabh Mukewar, Rocio Lopez, Aaron Brzezinski, Philip Hall, Bo Shen.   

Abstract

BACKGROUND: Renal involvement in patients with inflammatory bowel disease (IBD) has been well documented. However, there was a paucity of data on the frequency of renal insufficiency and its risk factors in this patient population. The aim of the study was to determine the frequency and factors associated with renal insufficiency within IBD inpatients.
METHODS: This case-control study was conducted on both Crohn's disease and ulcerative colitis inpatients in our tertiary care center from 2009 to 2010. Patients were identified as having renal insufficiency by the criterion of glomerular filtration rate < 60 mL/min/1.73 m. The glomerular filtration rate was further assessed against normal reference ranges. Risk factors for renal insufficiency were evaluated by univariable and multivariable analyses.
RESULTS: A total of 251 eligible patients were included. The frequency of renal insufficiency was 15.9% (95% confidence interval: 11.4-20.5), with 40 patients having a glomerular filtration rate <60 mL/min/1.73 m. Univariable analysis demonstrated several possible risk factors, including older age at admission (42.0 ± 16.2 years versus 57.6 ± 13.3 years, P < 0.001), and a longer median duration of IBD (9.0 years [interquartile range: 3.5-20.0] versus 25.0 years [interquartile range: 15.0-36.0], P < 0.001). The multivariable logistic analysis demonstrated that for every 5-year increase in age at the time of admission, the likelihood of having renal insufficiency increased by 30%.
CONCLUSION: Acute or chronic renal sufficiency in IBD inpatients was common, especially in elderly. Acute renal insufficiency can be medically reversed if properly treated. We recommend that renal function be closely monitored in IBD inpatients.

Entities:  

Mesh:

Year:  2013        PMID: 23689806     DOI: 10.1097/MIB.0b013e31828a661e

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  12 in total

1.  Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.

Authors:  Ravy K Vajravelu; Lawrence Copelovitch; Mark T Osterman; Frank I Scott; Ronac Mamtani; James D Lewis; Michelle R Denburg
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-01       Impact factor: 11.382

Review 2.  Renal manifestations in inflammatory bowel disease: a systematic review.

Authors:  Karen van Hoeve; Ilse Hoffman
Journal:  J Gastroenterol       Date:  2022-07-14       Impact factor: 6.772

3.  Differentiation of T Helper 17 Cells May Mediate the Abnormal Humoral Immunity in IgA Nephropathy and Inflammatory Bowel Disease Based on Shared Genetic Effects.

Authors:  Jianbo Qing; Changqun Li; Xueli Hu; Wenzhu Song; Hasna Tirichen; Hasnaa Yaigoub; Yafeng Li
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

Review 4.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Authors:  Mehmet Kanbay; Emine M Onal; Baris Afsar; Tuncay Dagel; Aslihan Yerlikaya; Adrian Covic; Nosratola D Vaziri
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

5.  Microbiome analysis reveals that Ralstonia is responsible for decreased renal function in patients with ulcerative colitis.

Authors:  Jung Min Kim; John Hoon Rim; Da Hye Kim; Hye-Youn Kim; Sung Kyoung Choi; Dong Yun Kim; Yo Jun Choi; Seyoung Yu; Jae Hee Cheon; Heon Yung Gee
Journal:  Clin Transl Med       Date:  2021-03

6.  Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study.

Authors:  Seona Park; Jaeyoung Chun; Kyung-Do Han; Hosim Soh; Kookhwan Choi; Ji Hye Kim; Jooyoung Lee; Changhyun Lee; Jong Pil Im; Joo Sung Kim
Journal:  World J Gastroenterol       Date:  2018-11-14       Impact factor: 5.742

7.  Characterization of the Effect of Renal Impairment on Upadacitinib Pharmacokinetics.

Authors:  Mohamed-Eslam F Mohamed; Sheryl Trueman; Tian Feng; Jaclyn Anderson; Thomas C Marbury; Ahmed A Othman
Journal:  J Clin Pharmacol       Date:  2019-01-11       Impact factor: 3.126

8.  Prevalence of Renal Stones Among Patients With Inflammatory Bowel Disease in Saudi Arabia.

Authors:  Mahmoud Mosli; Abdulrahman M Alzahrani; Rafeef A Bahafzalla; Tala A Gazzaz; Rahaf M Slaghour; Ghidah Z Altabsh; Sarah B Aljadani; Razan N Alturkestani; Sondos S Hussein; Abdullah Kashgary; Omar I Saadah
Journal:  Cureus       Date:  2021-06-21

9.  Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.

Authors:  Fabian Schnitzler; Matthias Friedrich; Johannes Stallhofer; Ulf Schönermarck; Michael Fischereder; Antje Habicht; Nazanin Karbalai; Christiane Wolf; Marianne Angelberger; Torsten Olszak; Florian Beigel; Cornelia Tillack; Burkhard Göke; Reinhart Zachoval; Gerald Denk; Markus Guba; Christian Rust; Norbert Grüner; Stephan Brand
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

10.  Can diffusion weighted imaging be used as an alternative to contrast-enhanced imaging on magnetic resonance enterography for the assessment of active inflammation in Crohn disease?

Authors:  Aysegul Cansu; Suleyman Bekircavusoglu; Sukru Oguz; Eser Bulut; Sami Fidan
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.